Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
OnKure Therapeutics, Inc.Listing on record | Sell | $3.4M | Unusual size | SEC | |
Immuneering CorpListing on record | Sell | $29.8 | SEC | ||
Immuneering CorpListing on record | Sell | $1.8K | SEC | ||
Immuneering CorpListing on record | Sell | $30.1 | SEC | ||
Immuneering CorpListing on record | Sell | $307 | SEC | ||
Immuneering CorpListing on record | Sell | $831.6 | SEC | ||
Immuneering CorpListing on record | Sell | $1.2M | SEC | ||
Immuneering CorpListing on record | Sell | $921 | SEC | ||
Immuneering CorpListing on record | Sell | $305 | SEC | ||
Ambrx Biopharma Cayman, Inc.Listing unverified | Buy | $10.9M | conv 48Unusual size | SEC | |
Ambrx Biopharma Cayman, Inc.Listing unverified | Buy | $6M | conv 20 | SEC | |
Ambrx Biopharma Cayman, Inc.Listing unverified | Buy | $8.4M | conv 27 | SEC | |
Ambrx Biopharma Cayman, Inc.Listing unverified | Buy | $5.1M | conv 11 | SEC | |
Ambrx Biopharma Cayman, Inc.Listing unverified | Buy | $2.7M | conv 10 | SEC | |
Ambrx Biopharma Cayman, Inc.Listing unverified | Buy | $2.5M | conv 33First in 12mo | SEC | |
Biomea Fusion, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |